Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Journal of Cheminformatics
|
November 8, 2022
Development of machine learning classifiers to predict compound activity on prostate cancer cell lines
Davide Bonanni, Luca Pinzi, Giulio Rastelli
Journal of Medicinal Chemistry
|
January 16, 2020
Computational Method for Structure-Based Analysis of SAR Transfer
Davide Bonanni, Marco L Lolli, Jürgen Bajorath
ACS Omega
|
September 9, 2021
Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry Applications
Andrea Citarella, Davide Moi, Luca Pinzi, et al.
Current Medicinal Chemistry
|
September 3, 2021
Dual Targeting Strategies on Histone Deacetylase 6 (HDAC6) and Heat Shock Protein 90 (Hsp90)
Davide Bonanni, Andrea Citarella, Davide Moi, et al.
RSC Advances
|
April 15, 2022
Synthesis of potent and selective HDAC6 inhibitors led to unexpected opening of a quinazoline ring
Davide Moi, Andrea Citarella, Davide Bonanni, et al.
European Journal of Medicinal Chemistry
|
August 26, 2023
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer
Davide Moi, Davide Bonanni, Silvia Belluti, et al.
Medchemcomm
|
November 2, 2019
Exploration of [2 + 2 + 2] cyclotrimerisation methodology to prepare tetrahydroisoquinoline-based compounds with potential aldo-keto reductase 1C3 target affinity
Ana R N Santos, Helen M Sheldrake, Ali I M Ibrahim, et al.
European Journal of Medicinal Chemistry
|
September 8, 2017
Hydroxytriazole derivatives as potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors discovered by bioisosteric scaffold hopping approach
Agnese C Pippione, Alessandro Giraudo, Davide Bonanni, et al.
European Journal of Medicinal Chemistry
|
June 26, 2018
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents
Laurent R Chiarelli, Matteo Mori, Daniela Barlocco, et al.
European Journal of Medicinal Chemistry
|
March 31, 2018
Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid
Agnese Chiara Pippione, Irene Maria Carnovale, Davide Bonanni, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Journal of Cheminformatics
|
November 8, 2022
Development of machine learning classifiers to predict compound activity on prostate cancer cell lines
Davide Bonanni, Luca Pinzi, Giulio Rastelli
Journal of Medicinal Chemistry
|
January 16, 2020
Computational Method for Structure-Based Analysis of SAR Transfer
Davide Bonanni, Marco L Lolli, Jürgen Bajorath
ACS Omega
|
September 9, 2021
Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry Applications
Andrea Citarella, Davide Moi, Luca Pinzi, et al.
Current Medicinal Chemistry
|
September 3, 2021
Dual Targeting Strategies on Histone Deacetylase 6 (HDAC6) and Heat Shock Protein 90 (Hsp90)
Davide Bonanni, Andrea Citarella, Davide Moi, et al.
RSC Advances
|
April 15, 2022
Synthesis of potent and selective HDAC6 inhibitors led to unexpected opening of a quinazoline ring
Davide Moi, Andrea Citarella, Davide Bonanni, et al.
European Journal of Medicinal Chemistry
|
August 26, 2023
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer
Davide Moi, Davide Bonanni, Silvia Belluti, et al.
Medchemcomm
|
November 2, 2019
Exploration of [2 + 2 + 2] cyclotrimerisation methodology to prepare tetrahydroisoquinoline-based compounds with potential aldo-keto reductase 1C3 target affinity
Ana R N Santos, Helen M Sheldrake, Ali I M Ibrahim, et al.
European Journal of Medicinal Chemistry
|
September 8, 2017
Hydroxytriazole derivatives as potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors discovered by bioisosteric scaffold hopping approach
Agnese C Pippione, Alessandro Giraudo, Davide Bonanni, et al.
European Journal of Medicinal Chemistry
|
June 26, 2018
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents
Laurent R Chiarelli, Matteo Mori, Daniela Barlocco, et al.
European Journal of Medicinal Chemistry
|
March 31, 2018
Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid
Agnese Chiara Pippione, Irene Maria Carnovale, Davide Bonanni, et al.
Page
of 2